{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:26:47Z","timestamp":1787074007559,"version":"build-2736575974"},"reference-count":12,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) vaccination prevents HPV-related cancers, yet uptake remains suboptimal. In France, routine vaccination targets early adolescence (11-14 years), with catch-up vaccination recommended up to age 26 years. Reimbursement extension to age 26 became effective in December 2025, after the present survey. Within the French Military Health Service (Service de Sant\u00e9 des Arm\u00e9es, SSA), HPV vaccines are generally not administered in primary care units; prevention therefore relies on identifying eligible service members and initiating vaccination through prescription and referral to community-based administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>A cross-sectional, anonymous online Knowledge, Attitudes, and Practices (KAP) survey was conducted in September 2025 among active-duty SSA military general practitioners (MGPs). The primary outcome was self-reported routine initiation of HPV vaccination via prescription. Responses were dichotomized as \u201cYes\u201d versus \u201cNo.\u201d Univariate and multivariate analyses were performed to identify individual factors associated with HPV vaccine prescription. Barriers (non-prescribers) and implementation difficulties (prescribers) were described. Model-based scenario analyses estimated predicted probabilities of routine initiation under modifiable levers (increased opportunities via prompts\/standardized visits, comfort with sexual-health discussions, and HPV knowledge), with uncertainty assessed using non-parametric bootstrap (500 resamples).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among approximately 800 active-duty military physicians contacted through institutional channels, 186 completed the survey and met the inclusion criteria for the present analysis, corresponding to approximately one quarter of contacted physicians. Among respondents, 70 (38%) reported routinely initiating HPV vaccination. Routine initiation was independently associated with gynecology-related clinical activity within the unit (aOR 2.53, 95% CI 1.03-6.46) and higher HPV knowledge (aOR 1.17 per point, 95% CI 1.02-1.36), and inversely associated with difficulty discussing sexual health (aOR 0.30, 95% CI 0.13-0.64). Sociodemographic characteristics were similar between groups. Among non-prescribers, the leading barrier was omission (\u201cI don\u2019t think about it,\u201d 65%), followed by lack of an on-site delivery pathway (\u201cvaccine unavailability within the unit,\u201d 47%); fear of refusal was uncommon. Scenario analyses suggested larger gains from increasing opportunities (routinized prompts\/standardized encounters) and improving communication comfort than from knowledge gains alone, with additive effects when combining levers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In SSA primary care, routine initiation of HPV vaccination via prescription appears constrained mainly by missed opportunities and organizational friction rather than clinician opposition. With expanded catch-up recommendations and extended reimbursement up to age 26 years, implementation efforts within the French armed forces are timely; systematic prompts, streamlined prescription-to-vaccination pathways, and brief communication-focused training may increase initiation rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/milmed\/usag392","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:38:06Z","timestamp":1785843486000},"source":"Crossref","is-referenced-by-count":0,"title":["Missed Opportunities for Human Papillomavirus Vaccine Prescription in French Military Primary Care: A KAP Survey With Scenario-Based Modeling"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9821-6501","authenticated-orcid":false,"given":"Pierre-Louis","family":"Conan","sequence":"first","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, H\u00f4pital National d\u2019Instruction des Arm\u00e9es B\u00e9gin , 69 avenue de Paris , Saint-Mand\u00e9, 94160,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Buch","sequence":"additional","affiliation":[{"name":"Acad\u00e9mie de Sant\u00e9 des Arm\u00e9es, Ecole du Val-de-Gr\u00e2ce , 1 place Alphonse Laveran , Paris, 75005,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"le Dault","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, H\u00f4pital National d\u2019Instruction des Arm\u00e9es Laveran , 34 boulevard Alphonse Laveran , Marseille, 13013,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Maugey","sequence":"additional","affiliation":[{"name":"Centre d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique des Arm\u00e9es , Camp Sainte-Marthe, 408 rue Jean Queillau , Marseille, 13014,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Marsaa","sequence":"additional","affiliation":[{"name":"9\u00e8me Centre M\u00e9dical des Arm\u00e9es, 150\u00e8me Antenne M\u00e9dicale , 2 rue Mass\u00e9na , Toulon, 83800,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Charton","sequence":"additional","affiliation":[{"name":"Service de Pneumologie, H\u00f4pital National d\u2019Instruction des Arm\u00e9es Percy , 101 avenue Henri Barbusse , Clamart, 92140,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Vanquaethem","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital National d\u2019Instruction des Arm\u00e9es B\u00e9gin , 69 avenue de Paris , Saint-Mand\u00e9, 94160,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Laitselart","sequence":"additional","affiliation":[{"name":"Service d\u2019Anesth\u00e9sie, H\u00f4pital National d\u2019Instruction des Arm\u00e9es Percy , 101 avenue Henri Barbusse , Clamart, 92140,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ficko","sequence":"additional","affiliation":[{"name":"Acad\u00e9mie de Sant\u00e9 des Arm\u00e9es, Ecole du Val-de-Gr\u00e2ce , 1 place Alphonse Laveran , Paris, 75005,","place":["France"]},{"name":"Service de Maladies Infectieuses et Tropicales, H\u00f4pital National d\u2019Instruction des Arm\u00e9es Laveran , 34 boulevard Alphonse Laveran , Marseille, 13013,","place":["France"]},{"name":"Centre d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique des Arm\u00e9es , Camp Sainte-Marthe, 408 rue Jean Queillau , Marseille, 13014,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026081812380226900_usag392-B1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"2026081812380226900_usag392-B2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2026081812380226900_usag392-B3","author":"Haute Autorit\u00e9 de Sant\u00e9."},{"key":"2026081812380226900_usag392-B4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"2026081812380226900_usag392-B5","doi-asserted-by":"publisher","first-page":"usab562","DOI":"10.1093\/milmed\/usab562","article-title":"Factors associated with human papillomavirus vaccine initiation and compliance among U.S. Military service members","volume":"188","author":"Matsuno","year":"2023","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/milmed\/usab443","article-title":"HPV-related cancers: a growing threat to U.S. Military health and readiness","volume":"187","author":"Seay","year":"2022","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/milmed\/usac190","article-title":"Knowledge and attitudes regarding human papillomavirus among active duty service members at a large military base","volume":"188","author":"Ward","year":"2023","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.7205\/MILMED-D-15-00477","article-title":"Improving human papillomavirus vaccinations in military women","volume":"181","author":"Wedel","year":"2016","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B9","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1093\/milmed\/usae490","article-title":"Human papillomavirus (HPV) vaccination rates among U.S. Military veteran females and males and non-Veterans in the National Health Interview Survey","volume":"190","author":"Dubiel","year":"2025","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/milmed\/usab232","article-title":"Mandatory HPV vaccination; opportunity to save lives, improve readiness and cut costs","volume":"186","author":"Sitler","year":"2021","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/milmed\/usae559","article-title":"Updates in human papillomavirus vaccination to improve medical readiness in active duty service members","volume":"190","author":"Hope","year":"2025","journal-title":"Mil Med"},{"key":"2026081812380226900_usag392-B12","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1093\/milmed\/usad428","article-title":"HPV vaccine usage among the U.S. Military academy corps of cadets (2018-2025)","volume":"189","author":"Brasko","year":"2024","journal-title":"Mil Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag392\/70685901\/usag392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article-pdf\/doi\/10.1093\/milmed\/usag392\/70685901\/usag392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:09Z","timestamp":1787071089000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/advance-article\/doi\/10.1093\/milmed\/usag392\/8763921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1093\/milmed\/usag392","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"usag392"}}